230 related articles for article (PubMed ID: 21423852)
1. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.
Kissinger P; Mena L; Levison J; Clark RA; Gatski M; Henderson H; Schmidt N; Rosenthal SL; Myers L; Martin DH
J Acquir Immune Defic Syndr; 2010 Dec; 55(5):565-71. PubMed ID: 21423852
[TBL] [Abstract][Full Text] [Related]
2. The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women.
Gatski M; Martin DH; Levison J; Mena L; Clark RA; Murphy M; Henderson H; Schmidt N; Kissinger P
Sex Transm Infect; 2011 Apr; 87(3):205-8. PubMed ID: 21278401
[TBL] [Abstract][Full Text] [Related]
3. Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women.
Gatski M; Mena L; Levison J; Clark RA; Henderson H; Schmidt N; Rosenthal SL; Martin DH; Kissinger P
Sex Transm Dis; 2010 Aug; 37(8):502-5. PubMed ID: 20502393
[TBL] [Abstract][Full Text] [Related]
4. A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women.
Balkus JE; Richardson BA; Mochache V; Chohan V; Chan JD; Masese L; Shafi J; Marrazzo J; Farquhar C; McClelland RS
Sex Transm Dis; 2013 Jun; 40(6):499-505. PubMed ID: 23677023
[TBL] [Abstract][Full Text] [Related]
5. The influence of ART on the treatment of Trichomonas vaginalis among HIV-infected women.
Adamski A; Clark RA; Mena L; Henderson H; Levison J; Schmidt N; Gebrekristos HT; Martin DH; Kissinger P
Clin Infect Dis; 2014 Sep; 59(6):883-7. PubMed ID: 24917661
[TBL] [Abstract][Full Text] [Related]
6. A Comparison of Single-Dose Versus Multidose Metronidazole by Select Clinical Factors for the Treatment of Trichomonas vaginalis in Women.
Muzny CA; Mena LA; Lillis RA; Schmidt N; Martin DH; Kissinger P
Sex Transm Dis; 2022 Mar; 49(3):231-236. PubMed ID: 34694277
[TBL] [Abstract][Full Text] [Related]
7. The Association Between Human Immunodeficiency Virus and Bacterial Vaginosis and Metronidazole Treatment Failure for Trichomonas vaginalis.
Frechtling D; Chopra S; Ratnayake A; Kissinger PJ
Sex Transm Dis; 2024 Jan; 51(1):61-64. PubMed ID: 37921835
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.
Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD
J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365
[TBL] [Abstract][Full Text] [Related]
9. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis.
Wendel KA; Erbelding EJ; Gaydos CA; Rompalo AM
Clin Infect Dis; 2002 Sep; 35(5):576-80. PubMed ID: 12173132
[TBL] [Abstract][Full Text] [Related]
10. Premature with trichomoniasis: report of one case.
Wang JJ; Yeung LK; Sun LC; Sy LB; Leu FJ
Acta Paediatr Taiwan; 2005; 46(4):219-21. PubMed ID: 16381336
[TBL] [Abstract][Full Text] [Related]
11. Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues.
Kissinger P
BMC Infect Dis; 2015 Aug; 15():307. PubMed ID: 26242185
[TBL] [Abstract][Full Text] [Related]
12. Resistance of Trichomonas vaginalis infections to metronidazole in Auckland sexual health clinics: report of two cases.
Lo M; Reid M; Brokenshire M
N Z Med J; 2002 Aug; 115(1160):U147. PubMed ID: 12362204
[No Abstract] [Full Text] [Related]
13. [Therapeutic aspects of trichomoniasis].
Vukićević J; Jankicević J
Srp Arh Celok Lek; 2003; 131(3-4):156-61. PubMed ID: 14608880
[TBL] [Abstract][Full Text] [Related]
14. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
Seña AC; Bachmann LH; Hobbs MM
Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
[TBL] [Abstract][Full Text] [Related]
15. Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women.
Kissinger P; Secor WE; Leichliter JS; Clark RA; Schmidt N; Curtin E; Martin DH
Clin Infect Dis; 2008 Apr; 46(7):994-9. PubMed ID: 18444815
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
Kissinger PJ; Gaydos CA; Seña AC; Scott McClelland R; Soper D; Secor WE; Legendre D; Workowski KA; Muzny CA
Clin Infect Dis; 2022 Apr; 74(Suppl_2):S152-S161. PubMed ID: 35416973
[TBL] [Abstract][Full Text] [Related]
17. Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial.
Kissinger P; Muzny CA; Mena LA; Lillis RA; Schwebke JR; Beauchamps L; Taylor SN; Schmidt N; Myers L; Augostini P; Secor WE; Bradic M; Carlton JM; Martin DH
Lancet Infect Dis; 2018 Nov; 18(11):1251-1259. PubMed ID: 30297322
[TBL] [Abstract][Full Text] [Related]
18. Intravenous metronidazole, liquid tinidazole, and intra-vaginal boric acid to cure trichomonas in a patient with gastric bypass surgery.
Butt S; Tirmizi A
Int J STD AIDS; 2018 Jul; 29(8):825-827. PubMed ID: 29393008
[TBL] [Abstract][Full Text] [Related]
19. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
Mammen-Tobin A; Wilson JD
Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
[TBL] [Abstract][Full Text] [Related]
20. Treatment of metronidazole-resistant Trichomonas vaginalis.
Goldman LM; Upcroft JA; Workowski K; Rapkin A
Sex Health; 2009 Dec; 6(4):345-7. PubMed ID: 19917205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
